News
INCHEON, Korea I June 12, 2025 I Samsung Bioepis Co., Ltd. (“Samsung Bioepis”) today presented the long-term safety data of EPYSQLI™ (eculizumab; SB12), a ...
Samsung Bioepis Co., Ltd. ("Samsung Bioepis") today presented the long-term safety data of EPYSQLItm (eculizumab; SB12), a biosimilar to Soliris1, in paroxysmal nocturnal hemoglobinuria (PNH) at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback